Table 1.
Patients’ characteristics at baseline
Parameter | |
---|---|
Men/women | 7/3 |
Age (years) | 59.5 ± 17.6 |
BMI | 25.3 ± 4.0 |
T1DM/T2DM | 2/8 |
BG (mg/dL) | 410.3 ± 122.0 |
HbA1c (%) | 13.7 ± 2.5 |
Insulin (U/day) | 35.8 ± 22.3 |
Biguanides | 4 |
SGLT2i | 3 |
DPP4i | 2 |
Glinides | 1 |
α‐GI | 1 |
Liraglutide | 1 |
α‐GI, α‐glucosidase inhibitor; BG, blood glucose; BMI, body mass index; DPP4i, dipeptidyl peptidase‐4 inhibitor; HbA1c, hemoglobin A1c; SGLT2i, sodium–glucose co‐transporter 2 inhibitor; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.